Malcolm Gladwell on Massachusetts cancer research

In this week’s New Yorker, Malcolm Gladwell uses the history of leukemia drugs to get into a tale of the ongoing search for effective cancer treatments. He followed compound know as elesclomol from a successful Phase 2 studies through several Phase 3 clinical trials.  His main character is emeritus Harvard researcher Lan Bo Chen, who co-founded Lexington’s Synta Pharmaceuticals and did much of the research on elesclomol.  


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s